Skip to main content

and
  1. Article

    Open Access

    Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators

    Juvenile Dermatomyositis (JDM) is a rare autoimmune disease characterized by skin and muscle inflammation. The loss of nail fold capillary end row loops (ERL) is evidence of small vessel involvement in JDM. Th...

    Amer Khojah, Gabrielle Morgan, Marisa S. Klein-Gitelman in Pediatric Rheumatology (2023)

  2. Article

    Open Access

    Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity

    We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with dise...

    Lauren M. Pachman, Gabrielle Morgan, Marisa S. Klein-Gitelman in Pediatric Rheumatology (2023)

  3. Article

    Open Access

    Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases

    Despite the increased use of rituximab in treating pediatric patients with autoimmune diseases in the last decade, there are limited data on rituximab safety in those subjects who have a develo** immune syst...

    Amer M. Khojah, Michael L. Miller, Marisa S. Klein-Gitelman in Pediatric Rheumatology (2019)

  4. No Access

    Article

    Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus

    To delineate urine biomarkers that reflect kidney structural damage and predict renal functional decline in pediatric lupus nephritis (LN).

    Hermine I. Brunner, Gaurav Gulati, Marisa S. Klein-Gitelman in Pediatric Nephrology (2019)

  5. Article

    Open Access

    Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis

    To reduce treatment variability and facilitate comparative effectiveness studies, the Childhood Arthritis and Rheumatology Research Alliance (CARRA) published consensus treatment plans (CTPs) including one for...

    Jennifer C Cooper, Kelly Rouster-Stevens, Tracey B Wright in Pediatric Rheumatology (2018)

  6. Article

    Open Access

    Urine S100 proteins as potential biomarkers of lupus nephritis activity

    Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both seru...

    Jessica L. Turnier, Ndate Fall, Sherry Thornton in Arthritis Research & Therapy (2017)

  7. Article

    Open Access

    An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus

    Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disorder in which 20 % of patients are diagnosed in childhood. Childhood-onset SLE is associated with higher morbidity and mortality than ...

    Amit Thakral, Marisa S. Klein-Gitelman in Rheumatology and Therapy (2016)

  8. No Access

    Article

    Neonatal Lupus: What We Have Learned and Current Approaches to Care

    Neonatal lupus results from the passive transfer of autoantibodies; however, this transfer is not sufficient to cause disease. This article reviews clinical presentation with a focus on autoimmune-mediated con...

    Marisa S. Klein-Gitelman in Current Rheumatology Reports (2016)

  9. Article

    Open Access

    Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus

    Neuropsychiatric manifestations are common in childhood-onset systemic lupus erythematosus (cSLE) and often include neurocognitive dysfunction (NCD). Functional magnetic resonance imaging (fMRI) can measure br...

    Mark W DiFrancesco, Darren R Gitelman in Arthritis Research & Therapy (2013)

  10. Article

    Open Access

    Develo** consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous

    Rina Mina, Hermine Brunner, Barbara Anne Eberhard in Pediatric Rheumatology (2012)

  11. Article

    Open Access

    Asymptomatic intracardiac mass in a 14-year-old girl with granulomatosis with polyangiitis: Case report

    Granulomatosis with polyangiitis (GPA; Wegener’s granulomatosis) is a systemic necrotizing vasculitis of unknown etiology that commonly involves the upper airways, lungs, and kidneys. Cardiac involvement with ...

    Julia G Harris, David M Salvay, Marisa S Klein-Gitelman in Pediatric Rheumatology (2012)

  12. No Access

    Article

    Pediatric SLE—towards a comprehensive management plan

    In this Review, the authors describe the marked differences in clinical presentation, prognosis, disease assessment and treatment options that exist between pediatric and adult-onset systemic lupus erythematos...

    Hermine I. Brunner, Jennifer Huggins in Nature Reviews Rheumatology (2011)

  13. Article

    Initial Validation of a Novel Protein Biomarker Panel for Active Pediatric Lupus Nephritis

    Lupus nephritis (LN) is among the main determinants of poor prognosis in systemic lupus erythematosus (SLE). The objective of this study was to 1) isolate and identify proteins contained in the LN urinary prot...

    Michiko Suzuki, Kristina Wiers, Elizabeth B Brooks, Kenneth D Greis in Pediatric Research (2009)

  14. No Access

    Article

    Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis

    We hypothesized that neutrophil gelatinase-associated lipocalin (NGAL) is an early predictive biomarker of disease activity in lupus nephritis. NGAL in serial plasma (PNGAL) and urine (UNGAL) samples was measu...

    Michiko Suzuki, Kristina M. Wiers, Marisa S. Klein-Gitelman in Pediatric Nephrology (2008)

  15. No Access

    Article

    Systemic lupus erythematosus

    Systemic Lupus Erythematosus (SLE) of childhood is a complex and challenging disease which can occur at any age. Identification of disease early in it's course and aggressive, appropriate management leads to i...

    Marisa S. Klein-Gitelman, Michael L. Miller in The Indian Journal of Pediatrics (1996)